PRP therapy involves drawing a patients own blood, concentrating the platelets, and reinjecting them into the target area
E-Posters - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.02 - GENETICS, OMICS AND BIOMARKERS P2587 - ESOC25-1868 DYNAMIC GENE EXPRESSION IN EXPERIMENTAL SUBARACHNOID HEMORRHAGE Emelie Fungbrant 1 , Jesper Bmers 2 , Anja Holm Nordvang 3 , Kristian Agmund Haanes 4 , Lars Edvinsson 5 , Tiit Mathiesen 6 1 Department of Neurosurgery, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark, Department of Clinical Experimental Research, Glostrup Research Institute, Copenhagen University Hospital, Rigshospitalet Glostrup, 2600 Glostrup, Denmark., Copenhagen, Denmark, 2 Department of Clinical Experimental Research, Glostrup Research Institute, Copenhagen University Hospital, Rigshospitalet Glostrup, 2600 Glostrup, Denmark., copenhagen, Denmark, 3 Department of Clinical Experimental Research, Glostrup Research Institute, Copenhagen University Hospital, Rigshospitalet Glostrup, 2600 Glostrup, Denmark., Copenhagen, Denmark, 4 Department of Clinical Experimental Research, Glostrup Research Institute, Copenhagen University Hospital, Rigshospitalet Glostrup, 2600 Glostrup, Denmark, Department of Biology, Section of Cell Biology and Physiology, University of Copenhagen, Denmark, Copenhagen, Denmark, 5 Division of Experimental Vascular Research, Department of Clinical Sciences, Lund University Hospital, Lund, Sweden., Copenhagen, Denmark, 6 Department of Neurosurgery, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark, Copenhagen, Denmark Background and Aims: Delayed cerebral ischemia (DCI) following subarachnoid hemorrhage (SAH) leads to significant morbidity, with few patients returning to full-time employment
While early findings have generated considerable scientific interest, much of the current evidence remains limited to laboratory and preclinical research
Our objective is to compare the functional outcomes of very elderly (80 years) rtPA-treated patients versus younger patients Methods: Very elderly (VE) acute ischemic stroke patients treated with rtPA at a tertiary center in San Jos were retrospectively analyzed using our local dataset from February 2012 to December 2023
